Editorial Comment: Heart Transplantation, Cardiac Allograft Vasculopathy and Proliferation Signal Inhibitors
Guest Editor’s Introduction
Cardiac Allograft Vasculopathy: Differences in De Novo and Maintenance Heart Transplant Recipients
The Impact of Proliferation Signal Inhibitors on the Healthcare Burden of Major Adverse Cardiac Events Following Heart Transplantation
Case Report: Long-Term Outcome of a Heart Transplant Recipient Switched to Everolimus After an Acute Myocardial Infarction